Mechanisms of drug resistance in nutrient-depleted colorectal cancer cells: insights into lysosomal and mitochondrial drug sequestration
Biology Open · 2024
DOI: 10.1242/bio.060448 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biology Open, 2024. Verfasst von Serra Gülse Köse und 1 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Biology and Genetics Department, Baskent University, Ankara 06790, Turkey. Hauptthemen laut MEDLINE: Lysosomes, Colorectal Neoplasms, Drug Resistance, Neoplasm, Mitochondria. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Baskent University: Baskent Universitesi.
Abstract (Originalsprache)
This Review delves into the mechanisms behind drug resistance in colorectal cancer (CRC), particularly examining the role of nutrient depletion and its contribution to multidrug resistance (MDR). The study highlights metabolic adaptations of cancer cells as well as metabolic adaptations of cancer cells under low nutrient availability, including shifts in glycolysis and lipid metabolism. It emphasizes the significance of MDR1 and its encoded efflux transporter, P-glycoprotein (P-gp/B1), in mediating drug resistance and how pathways such as HIF1α, AKT, and mTOR influence the expression of P-gp/B1 under limited nutrient availability. Additionally, the Review explores the dual roles of autophagy in drug sensitivity and resistance under nutrient limited conditions. It further investigates the involvement of lysosomes and mitochondria, focusing on their roles in drug sequestration and the challenges posed by lysosomal entrapment facilitated by non-enzymatic processes and ABC transporters like P-gp/B1. Finally, the Review underscores the importance of understanding the interplay between drug sequestration, lysosomal functions, nutrient depletion, and MDR1 gene modulation. It suggests innovative strategies, including structural modifications and nanotechnology, as promising approaches to overcoming drug resistance in cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Biology and Genetics Department, Baskent University, Ankara 06790, Turkey.
ORCID-Profile: Aliye Ezgi Güleç Taşkıran
Förderung
- Baskent University: Baskent Universitesi
Zitieren
APA
Köse, S. G., & Güleç Taşkıran, A. E. (2024). Mechanisms of drug resistance in nutrient-depleted colorectal cancer cells: insights into lysosomal and mitochondrial drug sequestration. Biology Open. https://doi.org/10.1242/bio.060448
Vancouver
Köse SG, Güleç Taşkıran AE. Mechanisms of drug resistance in nutrient-depleted colorectal cancer cells: insights into lysosomal and mitochondrial drug sequestration. Biology Open. 2024. doi:10.1242/bio.060448
BibTeX
@article{Kse2024,
author = {Köse, Serra Gülse and Güleç Taşkıran, Aliye Ezgi},
title = {Mechanisms of drug resistance in nutrient-depleted colorectal cancer cells: insights into lysosomal and mitochondrial drug sequestration},
journal = {Biology Open},
year = {2024},
doi = {10.1242/bio.060448}
}
EUVIMED